We are a preclinical biopharmaceutical company developing next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases and ocular pain.
Symbol
Last Closing Price
$1.83
Anticipated Date
January 6, 2023
Underwriters
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277